Tolemy Bio

United Kingdom · Biotech · Healthtech · AI

Develops AI-enabled platform for cell biology research to help biopharma teams interpret and optimise experimental workflows

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Pre-Seed€1.4MBig Sur Ventures — Role not disclosedJME Ventures — Role not disclosedMasia — Role not disclosedNorrsken Evolve — Role not disclosed
Sourcestolemy.bio ↗